Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The drug trade between European countries and developing countries]

C Bruneton1, P Naboulet, B van der Heide

  • 1Réseau Médicaments et Développement ReMeD, Paris, France.

Medecine Tropicale : Revue Du Corps De Sante Colonial
|January 1, 1997
PubMed
Summary

Regulations for medicinal products in developing countries are poorly enforced, leading to numerous violations. Improved international cooperation and standardized regulations are crucial for ensuring drug quality and safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nutritional approach to management of Buruli ulcer in Côte d'Ivoire.

Medecine et sante tropicales·2019
Same author

[Practices of caregivers and national recommendations for treatment of malaria in Benin in 2009].

Bulletin de la Societe de pathologie exotique (1990)·2017
Same author

Launch meeting of the French-speaking network for Neglected Tropical Diseases.

Medecine et sante tropicales·2016
Same author

[Marisa: a pretty name, a hazardous ally].

Medecine et sante tropicales·2015
Same author

Development and validation of a 3ABC antibody ELISA in Australia for foot and mouth disease.

Australian veterinary journal·2014
Same author

[Drug utilization and HIV in West Africa Raguin G et al. published in issue No. 4/70 (Med Trop 2010; 70:319-20)].

Medecine tropicale : revue du Corps de sante colonial·2011

Area of Science:

  • Pharmaceutical quality control
  • International drug regulation
  • Global health security

Context:

  • Medicinal product quality in developing nations is under scrutiny.
  • A survey assessed regulations between European and developing countries.
  • High trade volumes highlight regulatory gaps.

Purpose:

  • To evaluate the content and enforcement of current medicinal product regulations.
  • To identify discrepancies in regulatory practices between exporting and importing nations.
  • To assess the impact of differing regulations on product quality.

Summary:

  • Regulations are inadequately enforced, resulting in frequent infractions.
  • Market status definitions and banned substance lists vary significantly.

Related Experiment Videos

  • Compliance with good manufacturing practices is often unverifiable due to origin determination difficulties.

    • Impact:

    • Poor enforcement jeopardizes public health in developing countries.
    • Standardization of regulations and international cooperation are essential.
    • Addressing these issues is vital to prevent medicinal products from being treated as mere commodities.